{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:19:01Z","timestamp":1783948741678,"version":"3.55.0"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"12","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although the amplified-in-breast cancer 1 (AIB1; SRC-3, ACTR, or NCoA3) was defined as a coactivator for androgen receptor (AR) by in vitro studies, its role in AR-mediated prostate development and prostate cancer remained unexplored. We report here that AIB1 is expressed in the basal and stromal cells but not in the epithelial cells of the normal mouse prostates. AIB1 deficiency only slightly delayed prostate growth and had no effect on androgen-dependent prostate regeneration, suggesting an unessential role of AIB1 in AR function in the prostate. Surprisingly, when prostate tumorigenesis was induced by the SV40 transgene in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, AIB1 expression was observed in certain epithelial cells of the prostate intraepithelial neoplasia (PIN) and well-differentiated carcinoma and in almost all cells of the poorly differentiated carcinoma. After AIB1 was genetically inactivated in AIB1\u2212\/\u2212\/TRAMP mice, the progression of prostate tumorigenesis in most AIB1\u2212\/\u2212\/TRAMP mice was arrested at the well-differentiated carcinoma stage. Wild-type (WT)\/TRAMP mice developed progressive, multifocal, and metastatic prostate tumors and died between 25 and 34 weeks. In contrast, AIB1\u2212\/\u2212\/TRAMP mice only exhibited PIN and early-stage well-differentiated carcinoma by 39 weeks. AIB1\u2212\/\u2212\/TRAMP prostates showed much lower cell proliferation than WT\/TRAMP prostates. Most AIB1\u2212\/\u2212\/TRAMP mice could survive more than 35 weeks and died with other types of tumors or unknown reasons. Our results indicate that induction of AIB1 expression in partially transformed epithelial cells is essential for progression of prostate tumorigenesis into poorly differentiated carcinoma. Inhibition of AIB1 expression or function in the prostate epithelium may be a potential strategy to suppress prostate cancer initiation and progression. [Cancer Res 2007;67(12):5965\u201375]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-3168","type":"journal-article","created":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T09:26:18Z","timestamp":1181985978000},"page":"5965-5975","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice"],"prefix":"10.1158","volume":"67","author":[{"given":"Arthur C-K.","family":"Chung","sequence":"first","affiliation":[{"name":"1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suoling","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liao","sequence":"additional","affiliation":[{"name":"1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Ching-Yi","family":"Tien","sequence":"additional","affiliation":[{"name":"1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman M.","family":"Greenberg","sequence":"additional","affiliation":[{"name":"2Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Xu","sequence":"additional","affiliation":[{"name":"1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,6,15]]},"reference":[{"key":"2022061622281239000_B1","doi-asserted-by":"crossref","unstructured":"Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol\u20082005; 23: 8146\u201351.","DOI":"10.1200\/JCO.2005.02.9751"},{"key":"2022061622281239000_B2","doi-asserted-by":"crossref","unstructured":"Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med\u20082003; 349: 366\u201381.","DOI":"10.1056\/NEJMra021562"},{"key":"2022061622281239000_B3","doi-asserted-by":"crossref","unstructured":"Liao L, Kuang SQ, Yuan Y, Gonzalez SM, O'Malley BW, Xu J. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3\/AIB1. J Steroid Biochem Mol Biol\u20082002; 83: 3\u201314.","DOI":"10.1016\/S0960-0760(02)00254-6"},{"key":"2022061622281239000_B4","doi-asserted-by":"crossref","unstructured":"Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol\u20082003; 17: 1681\u201392.","DOI":"10.1210\/me.2003-0116"},{"key":"2022061622281239000_B5","doi-asserted-by":"crossref","unstructured":"List HJ, Reiter R, Singh B, Wellstein A, Riegel AT. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res Treat\u20082001; 68: 21\u20138.","DOI":"10.1023\/A:1017910924390"},{"key":"2022061622281239000_B6","doi-asserted-by":"crossref","unstructured":"Anzick SL, Kononen J, Walker RL, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science\u20081997; 277: 965\u20138.","DOI":"10.1126\/science.277.5328.965"},{"key":"2022061622281239000_B7","unstructured":"Bautista S, Valles H, Walker RL, et al. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin Cancer Res\u20081998; 4: 2925\u20139."},{"key":"2022061622281239000_B8","doi-asserted-by":"crossref","unstructured":"McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell\u20082002; 108: 465\u201374.","DOI":"10.1016\/S0092-8674(02)00641-4"},{"key":"2022061622281239000_B9","doi-asserted-by":"crossref","unstructured":"McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol\u20081999; 69: 3\u201312.","DOI":"10.1016\/S0960-0760(98)00144-7"},{"key":"2022061622281239000_B10","doi-asserted-by":"crossref","unstructured":"Arimura A, vn Peer M, Schroder AJ, Rothman PB. The transcriptional co-activator p\/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6. J Biol Chem\u20082004; 279: 31105\u201312.","DOI":"10.1074\/jbc.M404428200"},{"key":"2022061622281239000_B11","doi-asserted-by":"crossref","unstructured":"Myers E, Hill AD, Kelly G, et al. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin Cancer Res\u20082005; 11: 2111\u201322.","DOI":"10.1158\/1078-0432.CCR-04-1192"},{"key":"2022061622281239000_B12","doi-asserted-by":"crossref","unstructured":"Louie MC, Zou JX, Rabinovich A, Chen HW. ACTR\/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol\u20082004; 24: 5157\u201371.","DOI":"10.1128\/MCB.24.12.5157-5171.2004"},{"key":"2022061622281239000_B13","doi-asserted-by":"crossref","unstructured":"Torchia J, Rose DW, Inostroza J, et al. The transcriptional co-activator p\/CIP binds CBP and mediates nuclear-receptor function. Nature\u20081997; 387: 677\u201384.","DOI":"10.1038\/42652"},{"key":"2022061622281239000_B14","doi-asserted-by":"crossref","unstructured":"Werbajh S, Nojek I, Lanz R, Costas MA. RAC-3 is a NF-\u03baB coactivator. FEBS Lett\u20082000; 485: 195\u20139.","DOI":"10.1016\/S0014-5793(00)02223-7"},{"key":"2022061622281239000_B15","doi-asserted-by":"crossref","unstructured":"Glaeser M, Floetotto T, Hanstein B, Beckmann MW, Niederacher D. Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas. Horm Metab Res\u20082001; 33: 121\u20136.","DOI":"10.1055\/s-2001-14938"},{"key":"2022061622281239000_B16","doi-asserted-by":"crossref","unstructured":"Zhou HJ, Yan J, Luo W, et al. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res\u20082005; 65: 7976\u201383.","DOI":"10.1158\/0008-5472.CAN-04-4076"},{"key":"2022061622281239000_B17","doi-asserted-by":"crossref","unstructured":"Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE, Robson CN. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br J Cancer\u20082001; 85: 1928\u201336.","DOI":"10.1054\/bjoc.2001.2179"},{"key":"2022061622281239000_B18","doi-asserted-by":"crossref","unstructured":"Wang Y, Wu MC, Sham JS, Zhang W, Wu WQ, Guan XY. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer\u20082002; 95: 2346\u201352.","DOI":"10.1002\/cncr.10963"},{"key":"2022061622281239000_B19","doi-asserted-by":"crossref","unstructured":"Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer\u20082000; 89: 217\u201323.","DOI":"10.1002\/1097-0215(20000520)89:3<217::AID-IJC2>3.0.CO;2-6"},{"key":"2022061622281239000_B20","doi-asserted-by":"crossref","unstructured":"Ghadimi BM, Schrock E, Walker RL, et al. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol\u20081999; 154: 525\u201336.","DOI":"10.1016\/S0002-9440(10)65298-4"},{"key":"2022061622281239000_B21","doi-asserted-by":"crossref","unstructured":"Torres-Arzayus MI, Font de Mora J, Yuan J, et al. High tumor incidence and activation of the PI3K\/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell\u20082004; 6: 263\u201374.","DOI":"10.1016\/j.ccr.2004.06.027"},{"key":"2022061622281239000_B22","doi-asserted-by":"crossref","unstructured":"Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley BW. The steroid receptor coactivator SRC-3 (p\/CIP\/RAC3\/AIB1\/ACTR\/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci U S A\u20082000; 97: 6379\u201384.","DOI":"10.1073\/pnas.120166297"},{"key":"2022061622281239000_B23","doi-asserted-by":"crossref","unstructured":"Kuang SQ, Liao L, Zhang H, Lee AV, O'Malley BW, Xu J. AIB1\/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Cancer Res\u20082004; 64: 1875\u201385.","DOI":"10.1158\/0008-5472.CAN-03-3745"},{"key":"2022061622281239000_B24","doi-asserted-by":"crossref","unstructured":"Kuang SQ, Liao L, Wang S, Medina D, O'Malley BW, Xu J. Mice lacking the amplified in breast cancer 1\/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Cancer Res\u20082005; 65: 7993\u20138002.","DOI":"10.1158\/0008-5472.CAN-05-1179"},{"key":"2022061622281239000_B25","doi-asserted-by":"crossref","unstructured":"Louie MC, Yang HQ, Ma AH, et al. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci U S A\u20082003; 100: 2226\u201330.","DOI":"10.1073\/pnas.0437824100"},{"key":"2022061622281239000_B26","unstructured":"Gingrich JR, Barrios RJ, Morton RA, et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res\u20081996; 56: 4096\u2013102."},{"key":"2022061622281239000_B27","doi-asserted-by":"crossref","unstructured":"Sugimura Y, Cunha GR, Donjacour AA. Morphogenesis of ductal networks in the mouse prostate. Biol Reprod\u20081986; 34: 961\u201371.","DOI":"10.1095\/biolreprod34.5.961"},{"key":"2022061622281239000_B28","doi-asserted-by":"crossref","unstructured":"Kaplan-Lefko PJ, Chen TM, Ittmann MM, et al. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate\u20082003; 55: 219\u201337.","DOI":"10.1002\/pros.10215"},{"key":"2022061622281239000_B29","doi-asserted-by":"crossref","unstructured":"Nishihara E, Yoshida-Komiya H, Chan CS, et al. SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells. J Neurosci\u20082003; 23: 213\u201322.","DOI":"10.1523\/JNEUROSCI.23-01-00213.2003"},{"key":"2022061622281239000_B30","doi-asserted-by":"crossref","unstructured":"Mussi P, Liao L, Park SE, et al. Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland. Proc Natl Acad Sci U S A\u20082006; 103: 16716\u201321.","DOI":"10.1073\/pnas.0607768103"},{"key":"2022061622281239000_B31","doi-asserted-by":"crossref","unstructured":"Yuan Y, Liao L, Tulis DA, Xu J. Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen. Circulation\u20082002; 105: 2653\u20139.","DOI":"10.1161\/01.CIR.0000018947.95555.65"},{"key":"2022061622281239000_B32","doi-asserted-by":"crossref","unstructured":"Gioeli D. Signal transduction in prostate cancer progression. Clin Sci (Lond)\u20082005; 108: 293\u2013308.","DOI":"10.1042\/CS20040329"},{"key":"2022061622281239000_B33","doi-asserted-by":"crossref","unstructured":"Long RM, Morrissey C, Fitzpatrick JM, Watson RW. Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. Clin Sci (Lond)\u20082005; 108: 1\u201311.","DOI":"10.1042\/CS20040241"},{"key":"2022061622281239000_B34","doi-asserted-by":"crossref","unstructured":"Sugimura Y, Cunha GR, Donjacour AA. Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate. Biol Reprod\u20081986; 34: 973\u201383.","DOI":"10.1095\/biolreprod34.5.973"},{"key":"2022061622281239000_B35","unstructured":"Tomita K, van Bokhoven A, van Leenders GJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res\u20082000; 60: 3650\u20134."},{"key":"2022061622281239000_B36","doi-asserted-by":"crossref","unstructured":"De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology\u20081999; 53: 707\u201313.","DOI":"10.1016\/S0090-4295(98)00577-9"},{"key":"2022061622281239000_B37","doi-asserted-by":"crossref","unstructured":"Wang Y, Hayward S, Cao M, Thayer K, Cunha G. Cell differentiation lineage in the prostate. Differentiation\u20082001; 68: 270\u20139.","DOI":"10.1046\/j.1432-0436.2001.680414.x"},{"key":"2022061622281239000_B38","doi-asserted-by":"crossref","unstructured":"Huss WJ, Lai L, Barrios RJ, Hirschi KK, Greenberg NM. Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer. Prostate\u20082004; 61: 142\u201352.","DOI":"10.1002\/pros.20097"},{"key":"2022061622281239000_B39","doi-asserted-by":"crossref","unstructured":"Narayanan BA, Narayanan NK, Pittman B, Reddy BS. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Clin Cancer Res\u20082004; 10: 7727\u201337.","DOI":"10.1158\/1078-0432.CCR-04-0732"},{"key":"2022061622281239000_B40","doi-asserted-by":"crossref","unstructured":"Gupta S, Adhami VM, Subbarayan M, et al. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res\u20082004; 64: 3334\u201343.","DOI":"10.1158\/0008-5472.CAN-03-2422"},{"key":"2022061622281239000_B41","doi-asserted-by":"crossref","unstructured":"Williams TM, Hassan GS, Li J, et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem\u20082005; 280: 25134\u201345.","DOI":"10.1016\/S0022-5347(05)00110-2"},{"key":"2022061622281239000_B42","doi-asserted-by":"crossref","unstructured":"Yan J, Tsai SY, Tsai MJ. SRC-3\/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol Sin\u20082006; 27: 387\u201394.","DOI":"10.1111\/j.1745-7254.2006.00315.x"},{"key":"2022061622281239000_B43","doi-asserted-by":"crossref","unstructured":"Zhou G, Hashimoto Y, Kwak I, Tsai SY, Tsai MJ. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol\u20082003; 23: 7742\u201355.","DOI":"10.1128\/MCB.23.21.7742-7755.2003"},{"key":"2022061622281239000_B44","doi-asserted-by":"crossref","unstructured":"Louie MC, Revenko AS, Zou JX, Yao J, Chen HW. Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity. Mol Cell Biol\u20082006; 26: 3810\u201323.","DOI":"10.1128\/MCB.26.10.3810-3823.2006"},{"key":"2022061622281239000_B45","doi-asserted-by":"crossref","unstructured":"Mussi P, Yu C, O'Malley BW, Xu J. Stimulation of Steroid Receptor Coactivator-3 (SRC-3) Gene Overexpression by a Positive Regulatory Loop of E2F1 and SRC-3. Mol Endocrinol\u20082006; 20: 3105\u201319.","DOI":"10.1210\/me.2005-0522"},{"key":"2022061622281239000_B46","doi-asserted-by":"crossref","unstructured":"Lee SK, Kim HJ, Kim JW, Lee JW. Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53. Mol Endocrinol\u20081999; 13: 1924\u201333.","DOI":"10.1210\/mend.13.11.0365"},{"key":"2022061622281239000_B47","doi-asserted-by":"crossref","unstructured":"Goel A, Janknecht R. Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2\/Neu. J Biol Chem\u20082004; 279: 14909\u201316.","DOI":"10.1074\/jbc.M400036200"},{"key":"2022061622281239000_B48","doi-asserted-by":"crossref","unstructured":"Wu RC, Qin J, Hashimoto Y, et al. Regulation of SRC-3 (pCIP\/ACTR\/AIB-1\/RAC-3\/TRAM-1) coactivator activity by I\u03baB kinase. Mol Cell Biol\u20082002; 22: 3549\u201361.","DOI":"10.1128\/MCB.22.10.3549-3561.2002"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/12\/5965\/2568750\/5965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/12\/5965\/2568750\/5965.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T21:47:26Z","timestamp":1655416046000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/12\/5965\/533038\/Genetic-Ablation-of-the-Amplified-in-Breast-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,15]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2007,6,15]]},"published-print":{"date-parts":[[2007,6,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-3168","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495207.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495207","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22366578","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366578.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,15]]}}}